Malaria killed more than 600,000 people in 2020, according to a WHO report, with Africa being home to 95% of cases. The approved RTS,S vaccine could help change that.
The approval of the world’s first malaria vaccine RTS,S is a major breakthrough in the fight against a disease predominantly affecting African citizens.
This new vaccine could help save tens of thousands of young children, and requires four doses given after five months of age.
WHO Director-General Dr Tedros Adhanom Ghebreyesus described the news as historic, explaining that ‘the long-awaited malaria vaccine for children is a breakthrough for science, child health, and malaria control.’
Since 2019, an immunization pilot program in Kenya, Ghana, and Malawi has been underway, with more than 2.3 million doses being administered to children in moderate to high transmission regions.
Africa faces a higher risk of malaria infections than the rest of the world, despite the disease being preventable and curable.
According to WHO’s recent reports, an estimation of 241 million cases were reported in 2020. Globally, malaria caused 627,000 deaths in 2020. Africa accounts for 95% of all cases and 96% of total deaths.
Children are the most vulnerable group, accounting for 80% of deaths in sub-Saharan Africa. The rise in the number of infections and deaths was due to Covid-19.
The most affected countries are Nigeria, Democratic Republic of Congo, Tanzania, and Mozambique, which account for over half of the total malaria deaths.
Pregnant women remain vulnerable and are prone to mosquito bites especially in remote regions in Africa. In 2019, WHO estimates that over 12 million pregnancies were exposed to malaria, resulting in fetal loss, low birth weights, and other morbidities.
When discussing malaria control in sub-Saharan Africa, one must take into account regional challenges that can cause extra stresses and complications.
For one, the disease is closely associated with poverty. Malaria thrives mostly in regions with poor living conditions that foster the breeding of the mosquito vectors, and among people with poor socio-economic conditions that prevent them from accessing quality healthcare.
Additionally, sub-Saharan Africa is located in a region with a climate suitable for the reproduction and propagation of the female anopheles mosquito.
While the reason for the preponderance of malaria in this region is not limited to this, climatic conditions characterized by high temperature and abundant rainfall of sub-Saharan Africa play a major role in this disease.
Most sub-Saharan Africa countries lack the governmental support required for effective control of malaria.
Without judicious policies to safeguard against financial corruptive practices, most control strategies put in place invariably lose potency over time.
In addition to this, the health system in sub-Saharan Africa is characterized by limited access to medical services and products, lack of human resources for health, shortage of functioning health facilities, and an overall lack of quality healthcare service delivery.
Curbing malaria
Several measures have been in place for decades to try and control malaria.
From clearing bushy areas, to sleeping under insecticide-treated beds, these measures are less successful in poverty stricken areas of sub-Saharan Africa. Recently, China joined the 40 countries declared malaria-free by the WHO, making it the first country in the WHO Western Pacific Region to be awarded the certification.
The malaria vaccine mass roll-out is expected to begin by the end of 2022. The British GlaxoSmithKline (GSK) pharmaceutical giant said it would provide at least 15 million doses a year.
Taking into account the annual number of infections, the doses required could go up from 80 million to 100 million to fully reach the most affected regions.
Last week, the Gavi Alliance Board approved an investment of $155.7 million dollars for 2022-2025 to support the introduction, procurement, and delivery of vaccines to sub-Saharan Africa countries.
Let’s wait and see the progress in the near future.
I’m Derrick (He/Him), a Journalism and Mass Communication graduate from the Technical University of Mombasa, Kenya. Currently I write about trending topics and major issues affecting Africa for Thred, specifically concerning SDGs. View my Twitter here if you’d like to send me feedback.
With climate change raging over glacial ice, the landmark sanctuary was built to preserve Earth’s historical records held within the ice.
Time machines have long captured human imagination but have remained firmly in the realm of science fiction. Yet, understanding the past may not require such sophisticated piece of tech at all, for nature has already given us something alike – glacial ice.
Snow is composed partially of air, and...
The anticipation of having a baby is often clouded with uncertainty for Africa’s women as well as their families and healthcare providers due to an overwhelming number of pregnancy complications.
According to WHO, annually there are over 2 million stillbirths in the world, over half occurring in Sub-Saharan Africa.
These stillborn deaths are often preventable. Poor access to prenatal care, shortages of qualified health care providers, delayed responses to emergencies,...
Would people be more inclined to recycle their waste if they had a slim chance of winning $1,000 each time? Unsurprisingly, the data says yes.
A sense of moral responsibility or pang of guilt not cutting it? How about four figures of cold hard cash for that garbage?
Around 10 US states are already reimbursing people with a few cents for their empty bottles or cans, but what if the odd...
Dubbed ‘High Earners, Not Rich Yet’ (or Henrys), young Brits are feeling the pinch thanks to tax traps and inflation.
Unless you’ve found yourself in a high-paying job (or grew up with a silver spoon between your lips), £100k probably sounds like a lot of money. But young people earning these six figures claim to be struggling financially – both in the UK and across the pond.
Henrys, particularly...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
0 comments
